Coach — Ophthalmology
Eye disease is usually sorted by anatomy and treated where it shows: drops for pressure, injections for leaking vessels, surgery for a clouded lens. This chapter keeps those tools and asks a further question. Why do the energy-hungry cells of the retina, the optic nerve, the cornea, and the eye's surface glands so often run short in the first place?
Safety before ideas
These essays do not replace ophthalmology. The extended report states the limits plainly: "This does not replace ophthalmology. Sudden vision loss, flashes/floaters with a curtain, severe eye pain, chemical injury, or trauma are urgent — seek emergency / ophthalmic care. Do not stop IOP-lowering drops, anti-VEGF schedules, steroids, or other ocular drugs from a webpage." The essay on vessel blockages adds a line worth repeating here: "Sudden loss of vision in one eye, even if it clears, is an emergency: go to an emergency department right away, because a blocked eye artery is treated like a stroke." Decisions about drops, injections, lasers, and surgery stay with the ophthalmologist who knows the eye.
What this chapter proposes
Modern ophthalmology is very good at seeing and staging disease. It grades macular degeneration and diabetic retinopathy, maps the optic nerve and visual field in glaucoma, and understands local mechanisms such as drusen and complement, capillary dropout and VEGF, resistance to fluid outflow, and inflammation of the eye's surface. Its treatments are real achievements. In the report's words, "anti-VEGF transformed wet AMD and diabetic macular edema prognosis". Glaucoma surgery, laser, pressure-lowering drops, and cataract surgery protect sight every day.
The report's point is about what these tools are built to do. They "treat disease once it appears rather than prevent it, and the number of people living with these conditions keeps rising with aging populations and metabolic disease.” What they do not routinely ask, it says, is "why the cellular engines in RPE, photoreceptors, retinal vasculature, trabecular meshwork, lens epithelium, or ocular-surface glands may remain energetically compromised.” The working hypothesis of this chapter is that much chronic eye disease is the organ's response to cells that cannot make enough energy, set against a body-wide background of metabolic strain, poor light and sleep, and lost fitness. On this hypothesis, pressure does not by itself invent glaucoma, high blood sugar does not by itself invent diabetic retinopathy, and complement does not by itself invent macular degeneration. Each is real and each matters, but each may act on cells whose energy supply is already marginal. That reading adds questions upstream. It does not take away any treatment.
Topics in this chapter
The chapter begins with the eye essay, which treats the eye as the archetype of organ-level compensation. The extended report then takes up macular degeneration, read as the eye's attempt to clear debris and restore blood supply, and diabetic retinopathy, read as a response to oxygen shortage and a failure of the partnership between the retina's nerves and vessels. Glaucoma has its own report, and the hypertension essay explores how blood pressure, high and low, may be linked to glaucoma.
The front of the eye has its own essays. Dry eye and the ocular surface treats the tear glands and the eye's surface as energy-dependent tissues, and Fuchs' dystrophy describes a corneal pump that runs short of energy. At the back of the eye, retinitis pigmentosa and inherited retinal disease asks how much remaining energy capacity shapes the course of a genetic disease, and arterial and venous occlusions traces one vessel-wall failure that leaves two kinds of scar.
A few related essays sit outside the disease list. The report on blue eyes treats light iris color as a working hypothesis about adaptation to low light at high latitudes, with more glare and, in some studies, a higher risk of macular degeneration as trade-offs. Two essays discuss specific formulas as information, not as recommendations: AREDS3, on support for the retinal pigment epithelium, and HydroEye. Neither essay is a reason to start or stop anything without the eye doctor.
The chapter's full framing is in the extended report on ophthalmology. Talk with your own physician before changing medications or supplements.
See the notice at the top of this page. Working hypothesis, not medical advice.